Brazil's health minister tests positive for 19 in NYC



BRASILIA, Sept 21 (Reuters) - Brazil's Health Minister Marcelo Queiroga tested positive for COVID-19 hours after accompanying President Jair Bolsonaro to the United Nations General Assembly in New York on Tuesday, the government said.

Queiroga will remain in New York in quarantine, the government's communications office said.

"The minister is doing well," the statement said. It added that the rest of the delegation tested negative for the virus.

Queiroga told CNN Brasil that he had worn a mask the entire time that he was in the U.N. building.

Bolsonaro, a vaccine skeptic, defied U.N. rules that asked all those attending the assembly to be vaccinated. He has bragged about not getting vaccinated.

In his speech to world leaders at a meeting where the global coronavirus pandemic was top of the agenda, Bolsonaro said his government did not support the use of a vaccine passport and stood by treatment of the virus with unproven drugs such as the anti-malarial hydroxychloroquine.

He said Brazil's vaccination campaign against COVID-19 had been successful and that all adults who wanted a vaccine would be fully inoculated by November.

With unvaccinated diners barred from eating in New York restaurants, Bolsonaro and his entourage ate pizza on a sidewalk on their first night in the city on Sunday.

The health minister was the second member of the Brazilian delegation in New York to have tested positive. A young diplomat who was part of an advance team preparing Bolsonaro's visit tested positive on the weekend and was isolated.

COVID-19 has killed 591,440 Brazilians in the world's second-deadliest outbreak after the United States.

As vaccination advances in the country, the rolling 14-day average of COVID deaths has fallen to 519 a day, compared with almost 3,000 at the peak of the pandemic in April.


Reporting by Anthony Boadle; Editing by Stephen Coates

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.